Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
E-pub ahead of print

Altered balance between collagen formation and degradation after successful direct-acting antiviral therapy of chronic hepatitis C

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Hepatitis E during pregnancy: Maternal and foetal case-fatality rates and adverse outcomes—A systematic review

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co-infected HIV patients with cirrhosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis in Denmark: a nationwide cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Historical epidemiology of hepatitis C virus (HCV) in selected countries

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Tea Lund Laursen
  • Ida Falk Villesen
  • Diana Julie Leeming
  • Morten Asser Karsdal
  • Christina Sølund
  • Britta Tarp
  • Lena Hagelskjaer Kristensen
  • Charlotte Henneberg Holmboe
  • Peter Leuthcher
  • Alex Lund Laursen
  • Natasja Staehr Gudmann
  • Henning Grønbaek
Vis graf over relationer

The effect of direct-acting antiviral (DAA) therapy on extracellular matrix (ECM) turnover, a prominent feature of chronic hepatitis C (CHC), is unknown. ECM protein degradation and formation generate fragments reflecting the tissue turnover balance when quantified in the blood. PRO-C3 and PRO-C4 reflect type III and IV collagen formation; C3M and C4M are degradation markers of type III and IV. We aimed to assess the markers' dynamics with DAA therapy in CHC patients. Plasma PRO-C3, PRO-C4, C3M, and C4M were assessed before, during, and up till one year after 12-24 weeks of DAA therapy in 77 CHC patients with advanced fibrosis (n=14) or cirrhosis (n=63). Liver stiffness was evaluated using transient elastography. PRO-C3, C3M, and C4M levels decreased significantly (p<0.00001) while PRO-C4 was unchanged (p=0.20) during the study period. There was a steep decrease in the PRO-C3/C3M ratio during DAA therapy and follow-up (p<0.02). The PRO-C4/C4M ratio was unchanged (p>0.27). The dynamics of the collagen markers behaved similarly between patients with advanced fibrosis and cirrhosis. However, the cirrhosis patients had >20% higher levels of C3M, PRO-C4, and C4M at all time points (p<0.05). The collagen markers correlated with liver stiffness at baseline and follow-up.Markers of type III and IV collagen formation and degradation decreased during and after successful DAA therapy in CHC patients with advanced liver disease, and associated with disease severity. These results indicate an altered balance between collagen formation and degradation after viral clearance suggesting favourable effects on liver fibrosis.

OriginalsprogEngelsk
TidsskriftJournal of Viral Hepatitis
ISSN1352-0504
DOI
StatusE-pub ahead of print - 15 okt. 2020

Bibliografisk note

This article is protected by copyright. All rights reserved.

ID: 61113734